The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

In this photo taken on Thursday, Nov. 24, 2011, a worker inspects labels on vials containing H5N1 flu vaccine during production at the Beijing-based drug maker Sinovac Biotech Ltd. in Beijing.
In this photo taken on Thursday, Nov. 24, 2011, a worker inspects labels on vials containing H5N1 flu vaccine during production at the Beijing-based drug maker Sinovac Biotech Ltd. in Beijing.
(Andy Wong/AP)

March madness: 2013’s big sectors get shaken up

The month of March marked an important change in tone for market sector performance on both sides of the border. The leading market themes of 2013 suffered painful corrections while strength in previously lagging industries provided optimistic signs of a resurgent U.S. economy.

South of the border, the high-multiple top performers of last year had an extremely difficult month. The trend was particularly apparent in the biotechnology sector. The S&P 500 Pharmaceuticals, Biotechnology and Life Sciences Index fell 4.1 per cent for the month after providing investors with an impressive 42 per cent return for 2013.